AHK-Cu is a small copper-binding tripeptide consisting of the amino acid sequence alanine-histidine-lysine complexed with a copper(II) ion
Ensuring medication stability through proper refrigeration preserves the intended bioavailability for these precision approaches
This peptide interacts with receptors in various tissues, including muscle, bone, and fat cells, influencing processes such as protein synthesis, nutrient utilization, and tissue regeneration
"The substance's supposed benefits are largely based on anecdotal evidence, and the interest in it appears to be driven by those who stand to benefit from increased demand," Nina Zeldes, a researcher in Public Citizen's Health Research Group, told the committee
The Journal of Clinical Investigation 56 (5): 11251131